Olaparib | m-entrepreneurship.com

Product Name :
Olaparib

Search keywords :
Olaparib

drugId :
null

Target Vo:
Poly (ADP-Ribose) Polymerase 2

Target Vo Short Name :
PARP-2

Moa_Name:
Poly (ADP-Ribose) Polymerase 3 inhibitors

First Approval Country :
EU

First Approval Date Filter:
2014

Origin Company_Name :
Astrazeneca Plc

Active Company_Name :
Abbvie Deutschland Gmbh & Co Kg

Active Indication_Name:
Prostatic Neoplasms

In Active Indication_Name:
Melanoma

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Approved

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
SOD2 (Y20P09) Mouse mAb Description
Anti-Mouse LAG-3 Antibody (C9B7W) supplier
Phospho-HSF1 (Ser303/Ser307) Antibody: Phospho-HSF1 (Ser303/Ser307) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 57 kDa, targeting to Phospho-HSF1 (Ser303/Ser307). It can be used for WB,IHC-P assays with tag free, in the background of Human.

Author: Betaine hydrochloride

Related Posts